APOPLEXY OF A PITUITARY MACROADENOMA AS A SEVERE COMPLICATION OF PREOPERATIVE THYROTROPIN-RELEASING-HORMONE (TRH) TESTING

Citation
I. Szabolcs et al., APOPLEXY OF A PITUITARY MACROADENOMA AS A SEVERE COMPLICATION OF PREOPERATIVE THYROTROPIN-RELEASING-HORMONE (TRH) TESTING, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(4), 1997, pp. 234-236
Citations number
18
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
09477349
Volume
105
Issue
4
Year of publication
1997
Pages
234 - 236
Database
ISI
SICI code
0947-7349(1997)105:4<234:AOAPMA>2.0.ZU;2-Z
Abstract
The case history of a 54-year-old male suffering from pituitary macroa denoma with suprasellar extension is reported. A TRH-test with 200 mu g i.v. was followed by severe headache and vomiting after 60', and by development of ophthalmoplegia on the following day. Hyperdens patches on the CT scan showed haemorrhage into the tumor. A chromophobic aden oma with macroscopic and histological signs of haemorrhage was removed via the transsphenoidal route. In the postoperative period the ophtha lmoplegia gradually disappeared but central hypoadrenia and hypothyroi dism occurred. This is the second case in the literature showing that TRH alone and in a low dose may cause pituitary tumor apoplexy. It is concluded that TRH-testing is a risk for the patient with pituitary ap oplexy. If, due to the size of the tumor the patients have to be opera ted on in any case, and the test is not of essential diagnostic value, the TRH-test should be done only in selected cases. Its use in the po stoperative evaluation however is without risk for the patients.